Skip to main content

Closed

ACET: Adicet Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-73.9%

Financially safe

Stretched

Debt / equity0.10×

Interest coverage-1928.8×

Current ratio7.65×

Adicet Bio, Inc.

ACETNASDAQ Global Market·USD·Closed

Adicet Bio, Inc.

ACETNASDAQ·USD·Closed

$9.11

+0.55%

$9.11

+$0.05 (0.55%)

52W Range

27thpctl

Volume

1.27×avg

Mkt Cap

85.16MUSD

P/E

-0.6TTM

Div Yield

–ann

52W Range

27thpctl

Volume

1.27×avg

Market Cap

85.16MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings